Aurinia Pharmaceuticals AUPH
NASDAQ AUPH
$15.95 -0.24 (-1.51%)
At close: Oct 1, 2026 · 4:00 PM EDT

Aurinia Pharmaceuticals (AUPH) Net Equity Issued and Repurchased (2020 - 2026)

Updated

Aurinia Pharmaceuticals (AUPH) reported Net Equity Issued and Repurchased of $58.44 million for Q2 2026, compared with $1.3 million a year earlier.

Analysis

Aurinia Pharmaceuticals (AUPH) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Aurinia Pharmaceuticals' Net Equity Issued and Repurchased came in at $62.75 million, up 396.4% year-over-year; for FY2025, it was $14.19 million, up 73.3% from FY2024.

  • Net Equity Issued and Repurchased has increased for three consecutive years, though with a five-year compound annual growth rate of -40.3% (FY2020 to FY2025).
  • By year, Net Equity Issued and Repurchased came in at $8.19 million in FY2024 (+53.8%), $5.32 million in FY2023 (+178.5%), $1.91 million in FY2022 (-99.0%) and $196.74 million in FY2021 (+4.8%).
  • The Q2 2026 figure ranks as the highest quarterly Net Equity Issued and Repurchased since Q4 2021.
  • Year over year, Net Equity Issued and Repurchased gained in four of the last seven quarters, with growth averaging 62.1%.
  • The high point for year-over-year Net Equity Issued and Repurchased in five years was Q4 2023 (growth of 735.3%); the low point was Q4 2022 (a decline of 99.9%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $713,000 (Q1 2026), $1.61 million (Q4 2025) and $1.99 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Aurinia Pharmaceuticals 2.15 Bn 580.05 Mn 76.67 Mn 58.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 58.44 Mn
Mar 31, 2026 713,000.00
Dec 31, 2025 1.61 Mn
Sep 30, 2025 1.99 Mn
Jun 30, 2025 1.30 Mn
Mar 31, 2025 9.29 Mn
Dec 31, 2024 1.65 Mn
Sep 30, 2024 403,000.00
Jun 30, 2024 610,000.00
Mar 31, 2024 5.52 Mn
Dec 31, 2023 1.40 Mn
Sep 30, 2023 1.15 Mn
Jun 30, 2023 1.14 Mn
Mar 31, 2023 1.64 Mn
Dec 31, 2022 167,000.00
Jun 30, 2022 1.34 Mn
Mar 31, 2022 405,000.00
Dec 31, 2021 181.39 Mn
Sep 30, 2021 9.08 Mn
Jun 30, 2021 1.28 Mn
API Access

Aurinia Pharmaceuticals Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=AUPH&period=max&api_key=YOUR_API_KEY